- Home
- CSTL vs PRO Comparison
CSTL vs PRO Comparison
Compare CSTL & PRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- PRO
- Stock Information
- Founded
- CSTL 2007
- PRO 1985
- Country
- CSTL United States
- PRO United States
- Employees
- CSTL N/A
- PRO N/A
- Industry
- CSTL Medical Specialities
- PRO EDP Services
- Sector
- CSTL Health Care
- PRO Technology
- Exchange
- CSTL Nasdaq
- PRO Nasdaq
- Market Cap
- CSTL 946.1M
- PRO 1.1B
- IPO Year
- CSTL 2019
- PRO 2007
- Fundamental
- Price
- CSTL $29.81
- PRO $23.92
- Analyst Decision
- CSTL Strong Buy
- PRO Strong Buy
- Analyst Count
- CSTL 7
- PRO 8
- Target Price
- CSTL $37.57
- PRO $31.63
- AVG Volume (30 Days)
- CSTL 457.0K
- PRO 627.7K
- Earning Date
- CSTL 11-04-2024
- PRO 10-29-2024
- Dividend Yield
- CSTL N/A
- PRO N/A
- EPS Growth
- CSTL N/A
- PRO N/A
- EPS
- CSTL 0.21
- PRO N/A
- Revenue
- CSTL $311,878,000.00
- PRO $322,887,000.00
- Revenue This Year
- CSTL $49.05
- PRO $9.81
- Revenue Next Year
- CSTL N/A
- PRO $9.37
- P/E Ratio
- CSTL $143.32
- PRO N/A
- Revenue Growth
- CSTL 62.43
- PRO 8.66
- 52 Week Low
- CSTL $16.97
- PRO $16.64
- 52 Week High
- CSTL $35.84
- PRO $40.99
- Technical
- Relative Strength Index (RSI)
- CSTL 45.16
- PRO 66.27
- Support Level
- CSTL $27.24
- PRO $21.40
- Resistance Level
- CSTL $29.02
- PRO $23.69
- Average True Range (ATR)
- CSTL 1.93
- PRO 1.00
- MACD
- CSTL -0.46
- PRO 0.04
- Stochastic Oscillator
- CSTL 29.88
- PRO 92.81
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About PRO PROS Holdings Inc.
Pros Holdings Inc. is a provider of cloud-based revenue and profit realization software solutions to business-to-business and business-to-consumer companies. Its solutions assist customers in growing revenue, modernizing business processes, and supporting profitability by leveraging prescriptive analytics and data science-based decision-making technology. The company's solutions enable buyers to move fluidly across its customers' direct sales, partner, online, mobile, and emerging channels with personalized experiences. The firm generates revenue in the United States, Europe, Africa, Asia-Pacific, and Middle East regions.